Results 241 to 250 of about 137,133 (310)
ABSTRACT Objective Incretin‐based obesity therapies (IBTs), especially GLP‐1 receptor agonists (GLP‐1 RAs), effectively treat obesity and improve comorbidities. However, their impact on energy metabolism is unclear. A recent case of acute generalized muscle weakness in a patient with mitochondrial myopathy after tirzepatide exposure raises concerns ...
Bryn Falahee +2 more
wiley +1 more source
Dual Modulation of Adipogenesis and Lipolysis Augments Facial Adipose Tissue Restoration. [PDF]
Taebnia N +8 more
europepmc +1 more source
Depot‐Specific Insulin Receptor Isoform Dynamics During Human Adipose‐Derived Stem Cell Adipogenesis
Absolute quantification reveals depot‐specific insulin receptor (IR) isoform signatures in human adipose stem cells, with subcutaneous cells enriched in IRa and exhibiting greater adipogenic capacity and insulin responsiveness. The emergence of IR‐negative adipocytes highlights partially receptor‐independent pathways regulating human adipogenesis ...
Valentina Annamaria Genchi +10 more
wiley +1 more source
DPP4 Substrate Supplementation Protects From WNT-Induced Lipid Depletion in Dermal Adipocytes. [PDF]
Madhavan SR, Moore P, Ma Q, Atit RP.
europepmc +1 more source
The role of tryptophan hydroxylase‐1 in metabolic dysfunction‐associated steatotic liver disease
Silencing hepatic tryptophan hydroxylase 1 (TPH1) alleviated diet‐induced steatotic liver disease by reducing lipid accumulation, oxidative stress, inflammation, fibrosis, and hepatocyte apoptosis. These protective effects were mediated, at least in part, through restoration of Parkin‐dependent mitochondrial autophagy, identifying hepatic TPH1 as a ...
Shuangzhen Jia +3 more
wiley +1 more source
Reprogramming in delipidated adipocytes: metabolism, regulation and progress. [PDF]
Chang Z, Liao Y, Jiang W.
europepmc +1 more source
Pancreatic Panniculitis as the First Presentation of Pancreatic Adenocarcinoma
JEADV Clinical Practice, EarlyView.
Claudine Howard‐James +2 more
wiley +1 more source
Hyperglycemia‐driven cytokine activation initiates a sustained inflammatory cascade in diabetic kidney disease, promoting cellular injury and fibrogenic signaling. Integrating cytokine‐based biomarkers with risk stratification enables precision therapeutics that target inflammation and fibrosis, ultimately aiming to halt progression from early renal ...
Emmanuel Ifeanyi Obeagu
wiley +1 more source

